In-Silico Identification of the Best Compound Against Leishmania infantum: High Throughput Screening of All FDA Approved Drugs
Journal Title: Turkish Journal of Parasitology - Year 2019, Vol 43, Issue 4
Abstract
Objective: Current in-silico research was designed and administered for the screening of 20000 Food and Drug Administration-approved drug compounds with the goal of finding promising drugs against lipophosphoglycan (LPG) and γ-glutamylcysteine synthetase (γ-GCS) of Leishmania infantum. Methods: After the protein sequence of both targets was taken, the 3D structures of protein of interest were predicted and validated. Molecular docking was done among the two putative targets (LPG and γ-GCS) and approved compounds were selected using AutoDock 4.2 program to predict ligand-receptor interactions. Results: After docking experiment was done on 20000 drug compounds, a total number of seven ligands, two for γ-GCS receptor and five for LPG receptor, were assigned as novel, potent anti-leishmanial drugs based on their binding affinity and energy. Of those, five ligands possessed cytotoxic and anti-cancer characteristics and showed good binding capacity to LPG receptor with ΔGbinding up to 8.5 kcal/mol more negative; while two compounds showed good binding capacity to glutamyl receptor with ΔGbinding up to 7.8 kcal/mol more negative. Conclusion: The latest software-based methods are powerful tools for scanning and predicting new peptide templates specific to biological targets in organisms for new drug discovery. However, the use of in vitro and in vivo techniques is a requirement for better evaluation of the potential of projected ligands with the help of in-silico approaches, identifying molecular mechanism of action of the more active compounds is possible. This can help in defining the most likely molecular target, so that the subsequent optimization using in vitro and in vivo techniques can be undertaken.
Authors and Affiliations
Jasem Saki, Farnoush Shadnoush, Reza Arjmand, Fakher Rahim
Keywords
Related Articles
- EP ID EP676844
- DOI 10.4274/tpd.galenos.2019.6290
- Views 231
- Downloads 0
Molecular Characterization of Hydatid Cysts Cases in a Wild Boar and Mule in Turkey
Objective: Cystic echinococcosis (CE) is a zoonotic infection that affects humans, livestock and wild animals through the larval form of Echinococcus granulosus sensu lato (s.l.). Molecular and taxonomic studies carried...
Antileishmanial Activity of New Synthesized Schiff and Mannich (Morpholine) Base Compounds
Objective: Leishmaniasis is an important parasitic disease in many countries, including ours. A variety of drugs are currently used for its treatment. However, certain side effects of these drugs, such as teratogenicity,...
Retrospective Evaluation of 31 Malaria Cases Hospitalized in Our Clinic Between 2012-2018
Objective: Malaria is an infection disease caused by plamodium parasite. Sporadic cases have not been observed since 2011, but imported cases still present owing to travel. In this study, we aimed to evaluate labotauary...
The Efficacy of Hydroalcoholic Extracts of Prosopis farcta Against Leishmania major
Objective: Cutaneous leishmaniasis caused by Leishmania major (L. major) is an endemic disease in Iran. The current reference drugs, including Glucantime, possess high toxicity in addition to some side-effects. Therefore...
The Distribution of Pathogenic Intestinal Parasites in Sivas Cumhuriyet University Faculty of Medicine Research and Application Hospital between 2006-2018
Objective: The aim of this study was to determine the distribution of intestinal parasites in patients admitted to our hospital with gastrointestinal complaints in our city harboring sociocultural and economic changes, a...